Restore Flow Allografts
Restore Flow Allografts is dedicated to researching the restorative transplantation of donated human tissue for medical treatment.
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor | €0.0 | round | |
$14.0m Valuation: $14.0m | Acquisition | ||
| Total Funding | 000k | ||
Related Content
Restore Flow Allografts, founded in 2013, specializes in human tissue preservation, focusing on the processing and cryopreservation of vascular and cardiac allografts for transplantation. The company's business model centers on providing these biologic tissues to healthcare professionals, particularly vascular surgeons, for various medical procedures. Revenue is generated through tissue preservation services.
The company's offerings include a range of cryopreserved human tissue grafts, such as saphenous veins, femoral veins and arteries, and aortoiliac arteries. These allografts are utilized in a variety of vascular reconstructions, including peripheral bypass surgeries, creating hemodialysis access points, and treating aortic infections. Restore Flow also provides cardiac allografts for repair and reconstruction, such as ascending aorta and valve grafts and pulmonary artery patch grafts. A key benefit of these biologic implants is their resistance to infection. The tissue is sourced from deceased donors, authorized as anatomical gifts, and processed in accordance with FDA regulations.
In June 2013, the company secured $750,000 in a seed funding round from investor CV Ventures. A significant milestone occurred on November 10, 2016, when LeMaitre Vascular, Inc. acquired the assets of Restore Flow Allografts for approximately $14 million. At the time of the acquisition, Restore Flow had generated $3.7 million in revenue over the previous twelve months with break-even operating profits. Following the acquisition, the company's human tissue processing and cryopreservation operations are conducted at a facility in Fox River Grove, Illinois, and it operates as a brand under LeMaitre Vascular, distributing products in the United States, Canada, and the United Kingdom.
Keywords: allograft, cryopreservation, vascular tissue, cardiac tissue, human tissue graft, peripheral bypass, hemodialysis access, tissue preservation, biologic implants, saphenous vein graft, femoral artery graft, aortic reconstruction, vascular surgery, tissue transplantation, regenerative medicine, cryopreserved tissue, LeMaitre Vascular, surgical grafts, aortoiliac artery, cardiovascular reconstruction